# Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation

> **NCT06763081** · — · RECRUITING · sponsor: **University of Manitoba** · enrollment: 160 (estimated)

## Conditions studied

- Behavioral Activation
- Major Depressive Disorder
- Anxiety Disorders
- Antidepressant Drug Adverse Reaction
- Obsessive Compulsive Disorder (OCD)
- Major Depression

## Interventions

- **OTHER:** Not applicable- observational study

## Key facts

- **NCT ID:** NCT06763081
- **Lead sponsor:** University of Manitoba
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2025-09-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06763081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06763081, "Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06763081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*